Novartis, GlaxoSmithKline pricing case goes to the jury
Pharma Compliance Alert, July 2, 2008
After two weeks of testimony, a jury will decide whether Novartis and GlaxoSmithKline defrauded the Alabama State Medicaid Agency.
The state is seeking a combined $814 million in compensatory and punitive damages from the two companies, which it says caused the state to pay too much for prescription drugs between 1991 and 2005.
The case is the second to go to trial in Alabama. A jury found AstraZeneca guilty of fraud in February and said the company had to pay $215 million for alleged false and misleading reporting of drug prices reimbursed by the Alabama State Medicaid Agency. Circuit Court Judge Charles Price reduced the damage award to $160 million in June.
Alabama Attorney General (AG) Troy King filed suit against 73 pharmaceutical companies in 2005, claiming the companies illegally inflated prices. Two pharmaceutical companies, Dey and Takeda Pharmaceuticals, collectively agreed to pay $6.75 million to settle with the AG.
Comments
0 comments on “Novartis, GlaxoSmithKline pricing case goes to the jury ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched